PCI BIOTECH HOLDING ASA
Signals
- Under avvikling Selskapet er under frivillig avvikling.
PCI BIOTECH HOLDING ASA is registered as a public limited company in Oslo, Oslo with organisation number 991036393. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2007. Registered share capital is NOK 1.1m, divided into 37326390 shares. The company's stated purpose is: “Kreftbehandling og levering av legemidler basert på PCI-teknologien samt annen virksomhet i tilknytning til dette, herunder deltagelse i andre selskap med tilsvarende virksomhet gjennom egenkapital, lån eller ved avgivelse av garantier.”.
Former names: STARTUP 204 AS
Key figures · 2025
Financial health · 2025
Who owns PCI BIOTECH HOLDING ASA?
PCI BIOTECH HOLDING ASA has 20+ registered shareholders:
- FONDSAVANSE AS 10.5%
- JPMORGAN CHASE BANK, N.A., LONDON 5.0%
- CLEARSTREAM BANKING S.A. 4.3%
- NORDNET BANK AB 3.4%
- MP PENSJON PK 3.4%
- BNP PARIBAS 1.2%
- NORDNET LIVSFORSIKRING AS 1.2%
- SAXO BANK A/S 1.2%
- FORENEDE FORVALTNING AS 1.0%
- DANSKE BANK A/S 0.9%
- MORGAN STANLEY & CO. INT. PLC. 0.8%
- Lin Hu Zhang 0.7%
- Gunnar Leknes 0.6%
- John Bjarne Log 0.6%
- THE BANK OF NEW YORK MELLON SA/NV 0.6%
- Torbjørn Henning Wergeland 0.6%
- NORDEA BANK ABP 0.6%
- Ivar Hjørungnes 0.6%
- Per Ivar Nilsen 0.6%
- Jon Kristian Heimdal 0.5%
Which companies does PCI BIOTECH HOLDING ASA own?
PCI BIOTECH HOLDING ASA holds a stake in 1 company:
- PCI BIOTECH AS 100.0%
Frequently asked questions about PCI BIOTECH HOLDING ASA
Who owns PCI BIOTECH HOLDING ASA?
FONDSAVANSE AS is the largest registered owner, with 10.5%.
Where is PCI BIOTECH HOLDING ASA based?
PCI BIOTECH HOLDING ASA has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.